Nineteen years of qualification
Audited Supplier
In This Store
![(6R,7R)-7-Amino-8-oxo-3-vinyl-5-thia-1-azabicylo[4.2.0]oct-2-ene-2-carboxylic acid](https://eimg.pharmasources.com/image/product/default.jpg!200)
Zhejiang Yongning Pharmaceutical Co..Ltd is one of the leading enterprises in China Pharmaceutical Industry. It is also the first pharmaceutical company which make products from Cephalosprin side chain to finished product. It’s previous name was Zhejiang Yongning Pharmaceutical Factory which was established in 1974 and was a state-owned factory. It was reformed into private joint-stock company in 2006.
Company’s total assets are 800 million yuan, takes up an area of 180,000 m2, the staffs are more than 1200 including more than 300 engineers and technicians. The products have five classes of chemical and pharmaceutical intermediates, APIs and their preparations, Chinese medicines, health products and more than one hundred varieties and specifications. The products are sold well in all parts of the country and have been exported to Southeast Asia, America ,Europe etc.
One of the best 50 companies in China’s Pharmaceutical industry
The national member unit of 863 Program
The national key new high-tech enterprise of Torch Program
The largest management and the best economic benefits enterprise in Zhejiang Province
There is independent import and export right
More Than 60 kinds of new medicines, 6 products with independent intellectual property rights
Year of Establishment: 1974
Total Assets(USD): choose not to disclose
Total Number of Staff: more than 500
Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Quality Service
Other Competitive Advantages: Part of our products have been approved by USA FDA, Japan PMDA or South Korea FDA.
Patents and Copyrights: Yongning Pharma has more than 100 products, including 7 kinds with independent intellectual property right and a Protected National Chinese medicine. Yongning Pharma has obtained 27 patents at home and aboard, including 5 international patents. Ten among
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
